Nilotinib Hydrochloride, also known by the brand name Tasigna, is a prescription medication used specifically for treating a type of blood cancer called Chronic Myelogenous Leukemia (CML).
Here's a breakdown of key points:
- Medical Use: Targets CML, particularly cases associated with the Philadelphia chromosome genetic abnormality.
- Function: Belongs to a class of drugs called Bcr-Abl tyrosine kinase inhibitors. It works by hindering specific signals within cancer cells, thereby curbing their growth.
- Administration: Taken orally.
Additional Information:
- Developed to target resistance: Nilotinib was designed to be effective in situations where the initial CML treatment, imatinib, fails to control the condition.
- Approval: Received approval for medical use in the United States in 2007.
- Essential Medicines List: Included on the World Health Organization's list of essential medications.
- Generic Availability: Available as a generic medication.
External Links
Nilotinib Hydrochloride